Cargando…

Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China

BACKGROUND: Anti-β2GPI-domain I (β2GPI-DI) antibody is pathogenic in patients with antiphospholipid syndrome (APS), but its additional clinical associations and diagnostic value are controversial. METHODS: A total of 378 patients were included, of which 119 patients diagnosed with primary APS, 50 wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yangzhong, Hu, Chaojun, Qi, Wanting, Long, Yin, Huang, Can, Wang, Qian, Tian, Xinping, Zhao, Jiuliang, Li, Mengtao, Zeng, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Biomarker Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445380/ https://www.ncbi.nlm.nih.gov/pubmed/37607781 http://dx.doi.org/10.1136/lupus-2023-000924

Ejemplares similares

Extra-criteria clinical manifestations of antiphospholipid antibody should not be ignored
por: Huang, Can, et al.
Publicado: (2022)

Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome
por: Zhao, Yuan, et al.
Publicado: (2023)

Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients
por: Li, Siting, et al.
Publicado: (2023)

Evaluation of the Diagnostic Value of Non-criteria Antibodies for Antiphospholipid Syndrome Patients in a Chinese Cohort
por: Hu, Chaojun, et al.
Publicado: (2021)

Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population
por: Hu, Chaojun, et al.
Publicado: (2020)

Validation of three prediction models for thrombosis recurrence in antiphospholipid syndrome patients based on a prospective cohort
por: Zhao, Yuan, et al.
Publicado: (2023)

Comparison of Different Test Systems for the Detection of Antiphospholipid Antibodies in a Chinese Cohort
por: Hu, Chaojun, et al.
Publicado: (2021)

Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study
por: Qi, Wanting, et al.
Publicado: (2022)

Recurrent Non-stroke Central Neurologic Manifestations in Primary Antiphospholipid Syndrome
por: You, Hanxiao, et al.
Publicado: (2022)

Detection of IgA Antiphospholipid Antibodies Does not Improve Thrombotic Antiphospholipid Syndrome Classification: A two-Center Study
por: Su, Zhenzhen, et al.
Publicado: (2022)

Early Initiation of Anticoagulation Improves the Long-Term Prognosis in Patients With Antiphospholipid Syndrome Associated Portal Vein Thrombosis
por: You, Hanxiao, et al.
Publicado: (2021)

Loss of antiphospholipid antibody positivity post-thrombosis in SLE
por: Khawaja, Muznay, et al.
Publicado: (2020)

Sex Differences in Clinical Characteristics and Prognosis in Primary Thrombotic Antiphospholipid Syndrome
por: Huang, Yongfa, et al.
Publicado: (2022)

Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke
por: Naranjo, Laura, et al.
Publicado: (2021)

Immune Thrombocytopenia Could be an Independent Clinical Phenotype of Antiphospholipid Syndrome: A Prospective Cohort Study
por: Shi, Yu, et al.
Publicado: (2023)

Osteopontin is associated with disease severity and antiphospholipid syndrome in well characterised Swedish cases of SLE
por: Wirestam, Lina, et al.
Publicado: (2017)

A Novel Dimeric Inhibitor Targeting Beta2GPI in Beta2GPI/Antibody Complexes Implicated in Antiphospholipid Syndrome
por: Kolyada, Alexey, et al.
Publicado: (2010)

Non-Criteria Manifestations of Juvenile Antiphospholipid Syndrome
por: Miyamae, Takako, et al.
Publicado: (2021)

Criteria and Non-Criteria Antiphospholipid Antibodies in Antiphospholipid Syndrome: How Strong Are They Correlated?
por: Caraiola, Simona, et al.
Publicado: (2023)

Bilateral Ureterohydronephrosis after Intestinal Pseudo-obstruction in a Patient with Systemic Lupus Erythematosus
por: Qi, Wanting, et al.
Publicado: (2022)

Domain I of β2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation
por: Albay, A, et al.
Publicado: (2019)

Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added
por: Liu, Xiangjun, et al.
Publicado: (2022)

RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China
por: Huang, Can, et al.
Publicado: (2022)

The Challenges and Future Perspective for the Management of Systemic Lupus Erythematosus in China: A Concise Annual Report of 2020
por: Tian, Xinping, et al.
Publicado: (2022)

The Role of TLR4 on B Cell Activation and Anti-β (2)GPI Antibody Production in the Antiphospholipid Syndrome
por: Cheng, Si, et al.
Publicado: (2016)

IgA immunoglobulin isotype of rheumatoid factor in primary Sjögren’s syndrome
por: Maślińska, Maria, et al.
Publicado: (2021)

The efficacy of Mycophenolate mofetil for the treatment of Chinese Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2016)

Criteria and Non-Criteria Antiphospholipid Antibodies and Cancer in Patients with Involuntary Weight Loss
por: Caraiola, Simona, et al.
Publicado: (2023)

The infectious origin of the antiphospholipid syndrome: induction by passive transfer of anti-β2GPI antibodies induced by common bacteria
por: Blank, M, et al.
Publicado: (2003)

Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study
por: Bai, Wei, et al.
Publicado: (2022)

The molecular size of the extra-membrane domain influences the diffusion of the GPI-anchored VSG on the trypanosome plasma membrane
por: Hartel, Andreas J. W., et al.
Publicado: (2015)

Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer
por: Mo, Shaobo, et al.
Publicado: (2020)

Arih2 gene influences immune response and tissue development in chicken
por: Wu, Guanxian, et al.
Publicado: (2019)

Ocular manifestations of the antineutrophil cytoplasmic antibody and antiphospholipid syndromes
por: Khan, Sujoy
Publicado: (2013)

Neurological and Neuropsychiatric Manifestations of Antiphospholipid-Antibody Syndrome (APS)
por: Asif, Saba, et al.
Publicado: (2022)

Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE
por: Kennedy, William P, et al.
Publicado: (2015)

“Non-criteria” antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort
por: Liu, Tingting, et al.
Publicado: (2020)

Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome
por: Urbanski, Geoffrey, et al.
Publicado: (2018)

Evaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndrome
por: Zhang, Shulan, et al.
Publicado: (2016)

Cause of death in Chinese Takayasu arteritis patients
por: Li, Jing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_koroilm3qlc64269mvdhlqn24a